For intra-dentate gyrus injections, AKT inhibitor (AKTi) VIII (1,3-dihydro-1-(1-((4-(6-Phenyl-1H-imidazo[4,5-g]quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl)-2H-benzimidazol-2-one), an isozyme-selective AKTi specific for AKT1/2 (Calbiochem, La Jolla, CA, USA), was dissolved in dimethylsulfoxide (Sigma-Aldrich, Saint Louis, MO, USA) and injected at a dose of 3.0 g/l
However, the peptide category is much broader than those two medications, and this is where confusion and misinformation become a serious problem
Wegovy Also called semaglutide Key points about Wegovy Wegovy is used as weight loss treatment, together with healthy, balanced eating and regular physical activity as part of an overall weight loss plan
In this episode: Survodutide obesity and liver fat reduction data Mazdutide Phase 3 obesity and diabetes results UBT251 triple agonist weight loss data Berobenatide (MET-097) long-acting GLP-1 updates CagriSema diabetes and obesity trial results Zenagamtide (Amycretin) injectable and oral development Petrelintide amylin agonist info Future GLP-1, GIP, glucagon, and amylin therapies The future of obesity medicine is no longer just about who produces the most weight loss
